ResMed (RMD) PT Lowered to $220 at Mizuho

July 15, 2026 6:40 AM

Mizuho analyst Anthony Petrone lowered the price target on ResMed (NYSE: RMD) to $220.00 (from $235.00) while maintaining a Outperform rating.

No results found